Key result
Childhood hypertrophic cardiomyopathy was associated with a freedom from death or transplantation of 83% at 5 years and 76% at 10 years after presentation.
Population
80 Australian children who presented with primary hypertrophic cardiomyopathy at 0 to 10 years of age…
Design
Cohort
Follow-up
10 years
Authors
Loading...
Survival benchmarks inform pediatric HCM counseling; leaves open etiology-stratified trials.
Cohort (n=80)
Yes
In children presenting with hypertrophic cardiomyopathy, syndromal, genetic, and metabolic causes predominate, and freedom from death or transplantation is 76% at 10 years.
Nugent et al. (2005) conducted a cohort in Childhood hypertrophic cardiomyopathy (n=80). Childhood hypertrophic cardiomyopathy was associated with a freedom from death or transplantation of 83% at 5 years and 76% at 10 years after presentation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: